drugset / Trial / NCT03363269
Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the safety and efficacy of ID1201 in patients with mild Alzheimer's disease
Timeline
- Start
- 2016-04-12
- Primary completion
- 2018-12-31
- Completion
- 2019-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ID1201 | Unknown | 100 mg | — |
| Subject | ID1201 | Unknown | 200 mg | — |
| Subject | ID1201 | Unknown | 400 mg | — |